Institutional accumulation regime. Strong business quality combined with supportive market trend. Valuations remain demanding and supported by current metrics.
SENTINEL REVIEW
HFCL Limited (HFCL)β’Updated yesterday
π‘οΈ Sound Structural Profile: In Q2 FY2027, HFCL Limited reported a 143.2% YoY revenue expansion to βΉ2,569.2 Cr, with EBITDA margins expanding +6.3 pp to 25.6% and net profit swinging to βΉ394.2 Cr from a loss of βΉ71.9 Cr in the prior period. This operational turnaround is supported by a sustained trajectory since FY2026, with Q1 FY2027 and Q2 FY2027 both showing revenue growth above 100% YoY and EBITDA margins above 22.9%. This operational recovery is anchored by balance sheet strength from FY2026, where an audited CFO/PAT ratio of -1.15x (βΉ-378.1 Cr operating cash flow) and leverage of 35% (D/E of 0.35) provide substantial financial capacity despite 27.8% YoY debt growth. While active signals indicate easing margin compression and improving interest coverage, the company remains under monitored surveillance within Flagiumβs framework due to persistent operating leverage stress and cash conversion deficits.
- βRisk score improved (QoQ change: -5 pts)
- βProfitability margins pressure eased
- βGrowth expectations are demanding
- βMarket structure is strong
- βInstitutional flow regime is Neutral (-0.28Ο)
- βShare price is up +7.0% this quarter (from βΉ227.02 on 30 Sept to βΉ242.81)
- π’No severe forensic red flags active for HFCL
- π Track earnings quality and working capital trends in next filing
- π’Maintain routine quarterly surveillance; no governance escalation required
- 8.0 ptsEarnings Quality
- 3.9 ptsBalance Sheet Stress
- 3.3 ptsCompetitive Position
- 2.8 ptsGrowth Sustainability
Divergence Radar
Structural Matrix
Risk vs Price TimelineVisualizing the historical relationship between the structural risk score and stock price movement over time.
| Duration | Perf. | Sector Avg | Divergence |
|---|---|---|---|
| 1 Week | -8.3% | -1.37% | -6.92% |
| 1 Month | +17.91% | -6.43% | +24.34% |
| 6 Months | +109.26% | +0.1% | +109.17% |
| 1 Year | +220.92% | -5.02% | +225.94% |
| 2 Year | +107.16% | +35.37% | +71.79% |
| 3 Year | +276.86% | +130.26% | +146.59% |
Business Analysis Methodology
Business analysis focuses on structural risk inside the company. Flagium monitors earnings quality, balance sheet strength, liquidity, governance, competitive position, and growth sustainability to identify areas where risk may be increasing or decreasing before it becomes obvious in reported results.
Financial profile remains stable for now. Pressure is receding in profitability and earnings quality. This indicates that forensic pressure is currently receding. Risk levels are improving.
Risk Score Composition
Investment Risk Thesis
Current risk score has risen from 11 β 18 over 12 quarters.
- Operating cash flow sustainability
- Working capital discipline
Risk Drivers (Active Warnings)
No active warnings detected.
Primary Driver & Insights
Forensic risk profile is stable. No severe operating or financial anomalies are currently pressure-testing business resilience.
Active Risk Objects (7)Free Preview (2 of 7)
Revenue growth consistently lags behind sector median (11.0%).
Earnings quality is stabilizing. The reliance on non-operational items is receding.
Operating margin declined by 15.3 bps YoY for two consecutive quarters.
Operating efficiency is stabilizing. The rate of margin deterioration has slowed.
Unlock All 7 Forensic Signals (5 Additional Warnings Gated)
Free accounts preview the top 2 highest-impact warning signals. Upgrade to Flagium Pro to inspect all 7 active forensic detectors, multi-quarter duration streaks, and financial stress metrics for HFCL Limited.
Statutory Note: Forensic signals are algorithmic quantitative observations derived from publicly filed XBRL disclosures and do not constitute allegations of legal misconduct or investment recommendations.
Unlock Interactive Signal Evidence Dossier
Access complete multi-quarter financial evidence, 5-KPI snapshot strips, diagnostic hypotheses, and 1-page forensic PDF dossiers for HFCL Limited.
Structural Risk Attribution
Deterministic quarter-on-quarter causal decomposition grounded in statutory exchange filings.
Structural History Β· Last 12 QuartersHistorical Trajectory (12Q)
Risk improved moderately (-5.0 pts), driven by overall risk reduction across core indicators.
12-Quarter Structural Regimes & Landmark Inflections12Q Structural Regimes & Inflections
Risk deteriorated materially (+35.0 pts), driven by new Operating Leverage Stress (+9.6 pts) and new Low Interest Coverage (+7.7 pts).
Risk improved notably (-8.0 pts), driven by Margin Compression (-16.2 pts) and Low Interest Coverage (-9.6 pts), partially offset by Relative Growth Weakness (+3.2 pts).
Business Resilience & Benchmark Context
Overall: STRONGPEER COMPARISON MATRIX
Ranked surveillance & credit risk comparison against sector peers
Stable
Stable
Stable
Stable
Watch
Moderate Deterioration
* Peer comparison is based on risk signals, not valuation or returns.
Unlock 5-Year Forensic Divergence Cockpit
Access multi-year visual divergence charts (EBITDA vs CFO Cash Gap, Receivables Decoupling Spread, and Debt vs FCF Burn) for HFCL Limited.
FINANCIAL STATEMENTS
Working Capital & Forensic Monitor
Operating Cycle DisclosuresΒ·10 Fiscal Years
Working Capital Schedule (INR Cr)
| Metric / Ratio | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Trade Receivables(βΉ Cr) | 2,212 | 1,892 | 2,215 | 1,886 | β | β | β | β | β | β |
Inventories(βΉ Cr) | 1,416 | 899 | 774 | 758 | β | β | β | β | β | β |
Trade Payables(βΉ Cr) | 1,007 | 1,079 | 808 | 878 | β | β | β | β | β | β |
Net Working Capital(βΉ Cr) | 2,621 | 1,712 | 2,182 | 1,766 | β | β | β | β | β | β |
Working Capital / Sales(%) | 52.3% | 41.5% | 47.8% | 36.9% | β | β | β | β | β | β |
Cash Conversion & Operating Cycle (Days)
| Metric / Ratio | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Cash Conversion Cycle (CCC)(days) | 191d | 151d | 174d | 135d | β | β | β | β | β | β |
Debtor Days (DSO)(days) | 161d | 167d | 177d | 144d | β | β | β | β | β | β |
Inventory Days (DIO)(days) | 103d | 80d | 62d | 58d | β | β | β | β | β | β |
Creditor Days (DPO)(days) | 73d | 96d | 65d | 67d | β | β | β | β | β | β |
Forensic Accounting Monitor & Divergences
| Metric / Ratio | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Receivable Growth vs Sales (Ξ)(%) | -4.7% | -4.9% | +22.2% |